Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Advances in Therapy
|
December 20, 2024
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases
Min Yang, Manish Mittal, A Mark Fendrick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 12, 2017
Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γ agonist for treatment of dyslipidemia and metabolic disorders
Harilal Patel, Poonam Giri, Prakash Patel, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents
Preeti Raval, Mukul Jain, Amitgiri Goswami, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2021
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
Samer Gawrieh, Mazen Noureddin, Nicole Loo, et al.
Parasitology Research
|
April 20, 2023
Molecular identification and genetic characterization of Theileria and Anaplasma infection in sheep and goat of North Gujarat, India
Ankit Prajapati, Bhavesh Prajapati, Arun Patel, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 4, 2008
Modulation of PPAR receptor subtype selectivity of the ligands: aliphatic chain vs aromatic ring as a spacer between pharmacophore and the lipophilic moiety
Harikishore Pingali, Mukul Jain, Shailesh Shah, et al.
Open Forum Infectious Diseases
|
October 14, 2021
Corticosteroids Do Not Increase the Likelihood of Primary <i>Clostridioides difficile</i> Infection in the Setting of Broad-Spectrum Antibiotic Use
Travis J Carlson, Anne J Gonzales-Luna, Melissa F Wilcox, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent
Harikishore Pingali, Mukul Jain, Shailesh Shah, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
Design and synthesis of novel bis-oximinoalkanoic acids as potent PPAR alpha agonists
Harikishore Pingali, Mukul Jain, Shailesh Shah, et al.
Rheumatology and Therapy
|
November 24, 2021
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
Philip Conaghan, Stanley Cohen, Gerd Burmester, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Advances in Therapy
|
December 20, 2024
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases
Min Yang, Manish Mittal, A Mark Fendrick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
December 12, 2017
Preclinical evaluation of saroglitazar magnesium, a dual PPAR-α/γ agonist for treatment of dyslipidemia and metabolic disorders
Harilal Patel, Poonam Giri, Prakash Patel, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 1, 2011
Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents
Preeti Raval, Mukul Jain, Amitgiri Goswami, et al.
Hepatology (Baltimore, Md.)
|
April 3, 2021
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial
Samer Gawrieh, Mazen Noureddin, Nicole Loo, et al.
Parasitology Research
|
April 20, 2023
Molecular identification and genetic characterization of Theileria and Anaplasma infection in sheep and goat of North Gujarat, India
Ankit Prajapati, Bhavesh Prajapati, Arun Patel, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 4, 2008
Modulation of PPAR receptor subtype selectivity of the ligands: aliphatic chain vs aromatic ring as a spacer between pharmacophore and the lipophilic moiety
Harikishore Pingali, Mukul Jain, Shailesh Shah, et al.
Open Forum Infectious Diseases
|
October 14, 2021
Corticosteroids Do Not Increase the Likelihood of Primary <i>Clostridioides difficile</i> Infection in the Setting of Broad-Spectrum Antibiotic Use
Travis J Carlson, Anne J Gonzales-Luna, Melissa F Wilcox, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2008
Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent
Harikishore Pingali, Mukul Jain, Shailesh Shah, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
Design and synthesis of novel bis-oximinoalkanoic acids as potent PPAR alpha agonists
Harikishore Pingali, Mukul Jain, Shailesh Shah, et al.
Rheumatology and Therapy
|
November 24, 2021
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
Philip Conaghan, Stanley Cohen, Gerd Burmester, et al.
Page
of 7